PETNet releases 1st batch of Alzheimer's disease imaging agent

04/7/2010 | (free registration)

PETNet Solutions, a unit of Siemens Healthcare, has undertaken the first shipment of florbetapir, a molecular imaging agent from Avid Radiopharmaceuticals that is used to image the brain's beta-amyloid deposits, which are associated with Alzheimer's disease. The imaging agent is being tested in clinical trials involving U.S. and European patients suspected to have Alzheimer's disease or mild cognitive impairment.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT